Expoint โ€“ all jobs in one place
ืžืฆื™ืืช ืžืฉืจืช ื”ื™ื™ื˜ืง ื‘ื—ื‘ืจื•ืช ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ืžืขื•ืœื ืœื ื”ื™ื™ืชื” ืงืœื” ื™ื•ืชืจ

ื“ืจื•ืฉื™ื Dir Pharmacovigilance ื‘-ื˜ื‘ืข ื‘-India, Bengaluru

ืžืฆืื• ืืช ื”ื”ืชืืžื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื ืขื ืืงืกืคื•ื™ื ื˜! ื—ืคืฉื• ื”ื–ื“ืžื ื•ื™ื•ืช ืขื‘ื•ื“ื” ื‘ืชื•ืจ Dir Pharmacovigilance ื‘-India, Bengaluru ื•ื”ืฆื˜ืจืคื• ืœืจืฉืช ื”ื—ื‘ืจื•ืช ื”ืžื•ื‘ื™ืœื•ืช ื‘ืชืขืฉื™ื™ืช ื”ื”ื™ื™ื˜ืง, ื›ืžื• Teva. ื”ื™ืจืฉืžื• ืขื›ืฉื™ื• ื•ืžืฆืื• ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœืš ืขื ืืงืกืคื•ื™ื ื˜!
ื—ื‘ืจื” (1)
ืื•ืคื™ ื”ืžืฉืจื”
ืงื˜ื’ื•ืจื™ื•ืช ืชืคืงื™ื“
ืฉื ืชืคืงื™ื“ (1)
India
Bengaluru
ื ืžืฆืื• 2 ืžืฉืจื•ืช
29.06.2025
T

Teva Assoc Dir Regulatory Affairs India, Karnataka, Bengaluru

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
Accountable to support all activities related to Regulatory Life Cycle Management activities in Worldwide Markets (EU, US, Other Markets: CMC Variations, Renewals, PSUR, RMP, safety variations etc). Hiring, Training and...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื

ืžืฉืจื•ืช ื ื•ืกืคื•ืช ืฉื™ื›ื•ืœื•ืช ืœืขื ื™ื™ืŸย ืื•ืชืš

13.05.2025
T

Teva Dir Pharmacovigilance India, Karnataka, Bengaluru

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
The ICSR Global Operations Leader is accountable for the end-to-end execution of global ICSR operational activities, including oversight and proactive management of vendor-delivered services. Reporting to the Head of Systems...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
ื‘ื•ืื• ืœืžืฆื•ื ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœื›ื ื‘ื”ื™ื™ื˜ืง ืขื ืืงืกืคื•ื™ื ื˜. ื‘ืืžืฆืขื•ืช ื”ืคืœื˜ืคื•ืจืžื” ืฉืœื ื• ืชื•ื›ืœ ืœื—ืคืฉ ื‘ืงืœื•ืช ื”ื–ื“ืžื ื•ื™ื•ืช Dir Pharmacovigilance ื‘ื—ื‘ืจืช Teva ื‘-India, Bengaluru. ื‘ื™ืŸ ืื ืืชื ืžื—ืคืฉื™ื ืืชื’ืจ ื—ื“ืฉ ื•ื‘ื™ืŸ ืื ืืชื ืจื•ืฆื™ื ืœืขื‘ื•ื“ ืขื ืืจื’ื•ืŸ ืกืคืฆื™ืคื™ ื‘ืชืคืงื™ื“ ืžืกื•ื™ื, Expoint ืžืงืœื” ืขืœ ืžืฆื™ืืช ื”ืชืืžืช ื”ืขื‘ื•ื“ื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื. ื”ืชื—ื‘ืจื• ืœื—ื‘ืจื•ืช ืžื•ื‘ื™ืœื•ืช ื‘ืื–ื•ืจ ืฉืœื›ื ืขื•ื“ ื”ื™ื•ื ื•ืงื“ืžื• ืืช ืงืจื™ื™ืจืช ื”ื”ื™ื™ื˜ืง ืฉืœื›ื! ื”ื™ืจืฉืžื• ื”ื™ื•ื ื•ืขืฉื• ืืช ื”ืฆืขื“ ื”ื‘ื ื‘ืžืกืข ื”ืงืจื™ื™ืจื” ืฉืœื›ื ื‘ืขื–ืจืช ืืงืกืคื•ื™ื ื˜.